Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 551 publications

JCL Roundtable: Novel lipid management.

JCL Roundtable: Novel lipid management.

Journal: Journal of clinical lipidology
Published: October 11, 2025

Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.

Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.

Journal: Journal of the American Heart Association
Published: October 09, 2025

Atherogenic Dyslipidaemia in Diabetes: Burden and Challenges.

Atherogenic Dyslipidaemia in Diabetes: Burden and Challenges.

Journal: Acta medica Indonesiana
Published: October 06, 2025

Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed.

Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed.

Journal: Expert review of cardiovascular therapy
Published: October 03, 2025

Efficacy and safety of bempedoic acid in the prevention of cardiovascular events: results of the CLEAR Outcomes study and subgroup analyses

Efficacy and safety of bempedoic acid in the prevention of cardiovascular events: results of the CLEAR Outcomes study and subgroup analyses

Journal: Giornale italiano di cardiologia (2006)
Published: October 02, 2025

High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies.

High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies.

Journal: Journal of atherosclerosis and thrombosis
Published: September 18, 2025

Inclisiran (Leqvio) monotherapy for LDL-cholesterol reduction.

Inclisiran (Leqvio) monotherapy for LDL-cholesterol reduction.

Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025

Bempedoic Acid and the Uric Acid Paradox: Reflections on the Recent Meta-analysis.

Bempedoic Acid and the Uric Acid Paradox: Reflections on the Recent Meta-analysis.

Journal: Cardiovascular drugs and therapy
Published: August 28, 2025

Reply: Lipid Management in the Post-Statin Era: FDA Indications for Bempedoic Acid.

Reply: Lipid Management in the Post-Statin Era: FDA Indications for Bempedoic Acid.

Journal: JACC. Advances
Published: August 14, 2025

Strategic Lowering of LDL-cholesterol Post Ischemic Stroke: Identifying Optimal Targets, Timing, and Therapeutic Approaches.

Strategic Lowering of LDL-cholesterol Post Ischemic Stroke: Identifying Optimal Targets, Timing, and Therapeutic Approaches.

Journal: Thrombosis and haemostasis
Published: August 04, 2025

Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan.

Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan.

Journal: Current opinion in nephrology and hypertension
Published: July 29, 2025

Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm.

Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: July 21, 2025
Showing 1-12 of 551

Last Updated: 10/31/2025